1.Ali, SA, et al. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International Journal of Infectious Diseases 2009; 13: 9–19.
2.World Health Oragnization. Hepatitis C. WHO fact sheet no. 164. 2011.
3.Jafri, W, Subhan, A. Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response. Tropical Gastroenterology 2008; 29: 194–201.
4.Janjua, NZ, et al. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. Journal of Viral Hepatitis 2010; 17: 317–326.
5.World Health Organization. The global burden of disease: 2004 update, 2008.
6.Luby, SP, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiology and Infection 1997; 119: 349–356.
7.Waheed, Y, et al. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World Journal of Gastroenterology 2009; 15: 5647–653.
8.Ali, I, et al. Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa. Virology Journal 2011; 8: 296.
9.Abdul, MS, et al. Recycling of injection equipment in Pakistan. Infection Control and Hospital Epidemiology 2003; 24: 145–146.
10.Khan, AJ, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bulletin of the World Health Organization 2000; 78: 956–963.
11.Hamid, S, et al. PSG consensus statement on management of hepatitis C virus infection –2003. Journal of the Pakistan Medical Association 2004; 54: 146–150.
12.Luby, S, et al. Evaluation of blood bank practices in Karachi, Pakistan, and the government's response. Health Policy and Planning 2000; 15: 217–222.
13.Centers for Disease Control and Prevention. Establishment of a viral hepatitis surveillance system – Pakistan, 2009–2011. Morbidity and Mortality Weekly Report 2011; 60: 1385–1390.
14.Sievert, W, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver International 2011; 31 (Suppl. 2): 61–80.
16.Kermode, M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promotion International 2004; 19: 95–103.
17.Luby, S, et al. Long-term improvement in unsafe injection practices following community intervention. International Journal of Infectious Diseases 2005; 9: 52–59.
18.Khan, UR, et al. Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Tropical Medicine and International Health 2008; 13: 754–761.
19.Akhtar, S, et al. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. Journal of Viral Hepatitis 2004; 11: 527–535.
20.Bari, A, et al. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Tropical Medicine and International Health 2000; 6: 732–738.
21.Qureshi, H, et al. Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC Research Notes 2009; 2: 212.
22.Al-Jamal, M, et al. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi Journal of Kidney Diseases and Transplantation 2009; 20: 488–492.
23.Piazza, M, et al. Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. Journal of Medical Virology 1995; 45: 40–42.
24.World Health Organization. Global database on blood safety report 2004–2005. 2008.
25.Kassi, M, et al. Safe blood transfusion practices in blood banks of Karachi, Pakistan. Transfusion Medicine 2011; 21: 57–62.
26.Khuwaja, AK, Qureshi, R, Fatmi, Z. Knowledge about hepatitis B and C among patients attending family medicine clinics in Karachi. Eastern Mediterranean Health Journal 2002; 8: 787–793.